BioSpace News Archive

There are various drugs available in the market for the treatment of diseases like cancer, autoimmune disorders, and various other neurological disorders.

Dr. Reddy’s Laboratories Ltd. announced the launch of Over-the-Counter Nicotine Polacrilex Lozenges, 2 mg and 4 mg, the store brand version of Nicorette® Lozenges in the U.S. market.

Histogen Inc., a regenerative medicine company with a novel biological platform that replaces and regenerates tissues in the body, announced completion of patient enrollment ahead of schedule in its Phase 1b/2a clinical trial of HST 001, designed to assess the safety, tolerability and indicators of efficacy of HST 001 for the treatment of androgenic alopecia in men.

IDEAYA Biosciences, Inc., an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics, announced the Company will participate in the following upcoming investor conferences

Alan Kadish, M.D., president of New York Medical College and Touro College and University System, announced patent #10,709,883, issued by the United States Patent and Trademark Office for a revolutionary new bandage using Nano technology.

ChromaDex R&D program continues to pioneer NAD+ and Niagen® research and inks over 200 external research collaborations

Complete Response Letter Requests Additional Chemistry, Manufacturing, and Controls (CMC) and Human Factors Information

Cardiovascular Systems, Inc. will host a live webcast of its fiscal 2020 fourth-quarter conference call on Tuesday, August 4, 2020, at 3:30 p.m. CT.

Rapid Therapeutic Science Laboratories, Inc. (OTC: RTSL) an SEC fully-reporting, growth-oriented manufacturing and marketing company focused on employing FDA-approved Metered Dose Inhaler (MDI) technology to deliver aerosolized cannabinoids, such as CBD, CBG, and THC, announced today that it has delivered an additional 6,000 units (8,000 total) under its previously announced 100,000 unit order that was recently expanded to 250,000 units.

Aleafia Health Inc. (TSX: AH, OTC: ALEAF) (“Aleafia Health” or the “Company”) will announce its 2020 second quarter results on August 12, 2020 prior to market open.